STUDY ON IN VIVO RELEASE AND IN VIVO ABSORPTION OF CAMPTOTHECIN-LOADED POLYMERIC NANOPARTICLES: LEVEL A IN VITRO - IN VIVO CORRELATION

Authors

  • MAHALINGAM MANIKANDAN RESEARCH SCHOLARDEPARTMENT OF PHARMACYANNAMALAI UNIVERSITYCHIDAMBARAM-608002TAMILNADU
  • KRISHNAMOORTHY KANNAN ASST. PROFESSORDEPARTMENT OF PHARMACYANNAMALAI UNIVERSITYCHIDAMBARAM-608002TAMILNADU

Abstract

ABSTRACT
Objectives: The aim of this study was to develop an in vitro - in vivo correlation (IVIVC) for the prepared Camptothecin (CPT)-loaded polymeric
nanoformulation.
Methods: In this study, CPT-loaded polymeric nanoformulation was prepared by nanoprecipitation method using containing poly (methacrylic acidco-methyl

methacrylate) (polymer), poloxamer 188 (non-ionic surfactant), and β-cyclodextrin (stabilizer). In vitro release rate data were obtained
from prepared polymeric nanoformulation using the USP apparatus type 2. A single-dose, crossover pharmacokinetic study for the nanoformulation
was carried out in six albino rats. These data were used as the basis for the IVIVC model development.
Results: The plasma concentration of CPT was estimated by high-performance liquid chromatography. The pharmacokinetic parameters were
calculated from the plasma concentration of CPT and time data. Furthermore, the deconvolution of the in vivo concentration-time data was performed
using Wagner–Nelson method to estimate the in vivo drug release profile.
Conclusion: Therefore, a level A IVIVC was developed for CPT-loaded polymeric nanoformulation between dissolution percentage and intestinal
absorption in rats. The simplest way to demonstrate a correlation is to plot the percentage absorbed in vivo versus the percentage released in vitro at
the same time.
Keywords: Camptothecin, In vitro - in vivo correlation, Wagner–Nelson, Dissolution, Pharmacokinetics.

Downloads

Download data is not yet available.

References

REFERENCES

Peng CL, Lai PS, Lin FH, Yueh-Hsiu Wu S, Shieh MJ. Dual

chemotherapy and photodynamic therapy in an HT-29 human colon

cancer xenograft model using SN-38-loaded chlorin-core star block

copolymer micelles. Biomaterials 2009;30(21):3614-25.

Vargas A, Pegaz B, Debefve E, Konan-Kouakou Y, Lange N, Ballini JP,

et.al. Improved photodynamic activity of porphyrin loaded into

nanoparticles: An in vivo evaluation using chick embryos. Int J Pharm

;286(1-2):131-45.

Manikandan M, Kannan K. Camptothecin loaded poly (methacyclic

acid-Co-methyl-methyacrylate) nanoparticles: Fabrication,

characterization and cytotoxicity studies. Int J Pharm Pharm Sci

;7(10):135-40.

Leeson LJ. In vitro/in vivo correlations. Drug Inf J 1995;29(1):903-15.

Cardot JM, Beyssac E. In vitro/in vivo correlations: Scientific

implications and standardisation. Eur J Drug Metab Pharmacokinet

;18(1):113-20.

Sakore S, Chakraborty B. In vitro - In vivo correlation (IVIVC):

A strategic tool in drug development. J Bioequiv 2011;S3(1):1-12.

Emami J In vitro - In vivo correlation: From theory to applications.

J Pharm Pharm Sci 2006;9(2):169-89.

Food and Drug Administration. Guidance for Industry: Extended

Release Oral Dosage Forms: Development, Evaluation, and Application

of In vitro and In vivo Correlations. Vol. 62. No. 187. Rockville, MD:

U.S. Food and Drug Administration; 1997. p. 50619.

Machaa S, Yonga CL, Darringtonb T, Davisc MS, MacGregora TR,

Castlesa M, et al. In vitro - In vivo correlation for nevirapine extended

release tablets. Biopharm Drug Dispos 2009;30(9):542-50.

Uppoor VR. Regulatory perspectives on in vitro (dissolution)/in vivo

(bioavailability) correlations. J Control Release 2001;72(1-3):127-32.

Center for Drug Evaluation, USFDA. Guidance for industry: Immediate

release solid oral dosage forms: Scale up and post approval changes.

Drug Infor J 1995;29:903-15.

Reddy LH, Murthy RS. Etoposide-loaded nanoparticles made from

glyceride lipids: Formulation, characterization, in vitro drug release,

and stability evaluation. AAPS PharmSciTech 2005;6(2):E158-66.

Badhana S, Garud N, Garud A. Colon specific drug delivery of

mesalamine using Eudragit S100-coated chitosan microspheres for the

treatment of ulcerative colitis. Int Curr Pharm J 2013;2(3):42-8.

Abd El-Bary A, Aboelwafa AA, Al Sharabi IM. Influence of some

formulation variables on the optimization of pH-dependent, colontargeted,

sustained-release

mesalamine

microspheres.

AAPS

PharmSciTech

;13(1):75-84.

Da-Fang Z, Ke L, Jing-Hua X, Yue D, Yi-Fan Z. Pharmacokinetics

of 9-nitro-20(S)-camptothecin in rats. Acta Pharmacol Sin

;24(3):256-62.

Farrell C, Hayes S. IVIVC for oral drug delivery: Immediate release and

extended release dosage forms in pharmaceutical product development.

In: Chilukuri DM, Sunkara G, Young D, editors. In Vitro–In Vivo

Correlation. New York: Marcel Dekker; 2007. p. 125-40.

Published

01-05-2016

How to Cite

MANIKANDAN, M. ., and . K. . KANNAN. “STUDY ON IN VIVO RELEASE AND IN VIVO ABSORPTION OF CAMPTOTHECIN-LOADED POLYMERIC NANOPARTICLES: LEVEL A IN VITRO - IN VIVO CORRELATION”. Asian Journal of Pharmaceutical and Clinical Research, vol. 9, no. 3, May 2016, pp. 71-74, https://journals.innovareacademics.in/index.php/ajpcr/article/view/10095.

Issue

Section

Original Article(s)